Corporate

IOCL to double investments on R&D

State-run Indian Oil Corporation (IOCL) has proposed to double its investments on its Research and Development in order to develop newer technologies, a top company official said today. - Surinder Sud: Seeding R&D">Surinder Sud: Seeding R&D - MindTree joins Continua Health Alliance - "India to be a test-bed for global roll-outs" - Bambino has registered cent per cent growth: Das - 5 more auto testing, R&D centres by Sep 2011 - Get the basics right The company which has been spending Rs 100 crore a year on its R&D was hoping to double it this year to focus more on new technologies, IOCL Chairman S Behuria told reporters here today. "We are developing our own indegenous technology. We are spending Rs 100 crore on the R&D focusing in technologies. Now we are taking it to Rs 200 crore", he said. He said the purpose of the doubling on R&D was to improve the life cycle of "lubricants" which would subsequently improve the performance of vehicles. "Starting with lubricants, we will go to refining technologies. We also have renewable energies in the pipeline", he said.To a query on modernisation of refineries, he said that it was a "continuous" process. "Some of the refineries (in the country) are 100 years old, he said.

Quick Loans commented:

Having new benefit of new technology will definitely make their business more profitable as well.As it will also help them grow at the same time.

21.11.2011


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Sun gets support of RMG in battle against Taro
Sun Pharmaceutical Industries’ attempts to take over Israeli drug major Taro Pharmaceutical is gaining more support from independent advisory firms. RiskMetrics Group’s ISS Governance Services (RMG), an independent proxy advisory firm, has recommended that shareholders of Taro Pharmaceutical Industries vote against all the proposals made by Taro’s board of directors, including all of its nominees for election and re-election as directors in the upcoming Annual General Meeting (AGM) scheduled for December 31, Sun Pharma said in a press release.
Popular Articles
payday loan lenders

JLR acquisition a terrific decision: Ratan Tata
Tata Group Chief Ratan Tata today termed the buyout of Jaguar and Land Rover (JLR) as a "terrific decision" and hoped to bring back glory for the luxury brands.

Markets slip into red
Markets have erased all its gains and slipped into the red.